Capstone Investment Advisors
MRNA icon

Capstone Investment Advisors’s Moderna MRNA Stock Holding History

Capstone Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.03M Sell
138,300
-24,400
-15% -$1.14M 0.01% 360
2025
Q4 		$4.8M Buy
162,700
+18,200
+13% +$494K 0.01% 380
2025
Q3 		$3.73M Buy
+144,500
New +$4.03M 0.01% 561
2025
Q2 		– Sell
-10,900
Closed -$309K – 1687
2025
Q1 		$309K Sell
10,900
-45,800
-81% -$1.63M ﹤0.01% 1185
2024
Q4 		$2.36M Buy
56,700
+28,200
+99% +$1.35M 0.01% 795
2024
Q3 		$1.9M Buy
28,500
+4,100
+17% +$376K 0.01% 754
2024
Q2 		$2.9M Buy
24,400
+6,500
+36% +$823K 0.01% 607
2024
Q1 		$1.91M Sell
17,900
-31,900
-64% -$3.22M 0.01% 804
2023
Q4 		$4.95M Buy
49,800
+36,500
+274% +$3.07M 0.01% 531
2023
Q3 		$1.37M Buy
13,300
+3,400
+34% +$379K 0.01% 865
2023
Q2 		$1.2M Buy
9,900
+2,300
+30% +$307K 0.01% 806
2023
Q1 		$1.17M Buy
7,600
+900
+13% +$148K 0.01% 746
2022
Q4 		$1.2M Buy
6,700
+1,100
+20% +$180K 0.01% 871
2022
Q3 		$662K Buy
5,600
+300
+6% +$45.5K ﹤0.01% 1174
2022
Q2 		$757K Sell
5,300
-38,500
-88% -$5.5M ﹤0.01% 1103
2022
Q1 		$7.54M Buy
43,800
+25,900
+145% +$4.36M 0.02% 562
2021
Q4 		$4.55M Buy
17,900
+3,800
+27% +$1.11M 0.01% 853
2021
Q3 		$5.43M Buy
+14,100
New +$5.2M 0.01% 832
2021
Q1 		– Sell
-10,400
Closed -$1.09M – 1866
2020
Q4 		$1.09M Sell
10,400
-4,400
-30% -$445K ﹤0.01% 1055
2020
Q3 		$1.05M Buy
+14,800
New +$1.03M 0.01% 1005

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capstone Investment Advisors's MRNA Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Moderna (MRNA) in Q1 2026: 5,755 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #1371 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in MRNA as recently as Q3 2025.

Capstone Investment Advisors first reported a position in MRNA in Q3 2020 and has held it in 19 quarters since. The position peaked at $10.4M in Q4 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Capstone Investment Advisors held 5,755 shares of Moderna worth $292K as of Q1 2026.
  • Moderna was a new Capstone Investment Advisors position in Q1 2026.
  • Moderna made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1371 holding.
  • Capstone Investment Advisors first reported a position in Moderna in Q3 2020 and has held it in 19 quarters since.
  • Capstone Investment Advisors's Moderna position peaked at $10.4M in Q4 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.